NCT06587243 "Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
| NCT ID | NCT06587243 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins Bloomberg School of Public Health |
| Condition | Vaccination |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,100 participants |
| Start Date | 2025-11-24 |
| Primary Completion | 2026-08-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,100 participants in total. It began in 2025-11-24 with a primary completion date of 2026-08-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will compare the use of informational videos only, personal story videos only, and the combination of both, to see which is most effective in increasing HPV vaccination.
Eligibility Criteria
Inclusion Criteria: * Parents of 11-17 year olds not yet vaccinated against HPV Exclusion Criteria: * Parents whose adolescent children are already vaccinated against HPV * Participants who do not complete the survey * Participants who are unable or refuse to view and listen to videos on the participant's device
Contact & Investigator
Daniel Salmon, PhD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT06587243 clinical trial?
This trial is open to participants of all sexes, studying Vaccination. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06587243 currently recruiting?
Yes, NCT06587243 is actively recruiting participants. Contact the research team at mgoryn1@jh.edu for enrollment information.
Where is the NCT06587243 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT06587243 clinical trial?
NCT06587243 is sponsored by Johns Hopkins Bloomberg School of Public Health. The principal investigator is Daniel Salmon, PhD at Johns Hopkins University. The trial plans to enroll 1,100 participants.